Based on the recent earnings call, the company has reported strong third quarter results with adjusted earnings of $814 million and adjusted earnings per share of $2.45, showing year-over-year growth of 11% and 18% respectively. The company has demonstrated strong core business fundamentals, disciplined pricing, and continued capital deployment.

The Government business has shown positive momentum with a strong quarter, and the Commercial business has also performed well from an operating margin perspective. The company has grown insured Commercial membership and has seen strong underwriting results in their large group Commercial insured products. 

From a balance sheet perspective, the company's financial position, capital structure, and liquidity are all very strong with a debt-to-total-capitalization ratio of approximately 39.5%. 

The company has also increased its 2017 adjusted earnings per share guidance to approximately $9.75 based on continued strong performance in the third quarter. The updated 2017 projections are influenced by various factors such as adjusted revenue, total Health Care medical benefit ratio, adjusted pre-tax margin, adjusted expenses, and more.

Looking ahead, the company has highlighted various opportunities for growth in 2018, including projected above-industry growth in individual Medicare Advantage, strong growth in group Medicare Advantage products, and the potential to deploy additional capital to improve adjusted EPS growth.

Overall, the company's strong performance in the third quarter and its strategic initiatives position it well for continued growth and success in the future. Therefore, it is recommended to have an 'overweight' investment stance based on the company's recent earnings call.